MPH’s Creech: Proper treatment of S. aureus necessary with changing epidemiology
While skin and soft tissue infections such as MRSA are decreasing around 3% annually, rates of methicillin-susceptible Staphylococcus aureus, clindamycin and Bactrim resistance are rising, according to a presentation at the Infectious Diseases in Children Symposium.
“Staph does this every 10 to 15 years. It likes to hit the scene and fall back a little bit,” C. Buddy Creech, MD, MPH, associate professor of pediatrics, division of pediatric infectious diseases, and director of the Vanderbilt Vaccine Research Program, said in his presentation. “It then comes back a little different [the next time it appears]. In the 1970s, it was toxic shock syndrome. In the late 1980s, it was health care-associated MRSA. In the early 2000s, it was community-acquired MRSA.”